申请人:Littman Dan
公开号:US20130065842A1
公开(公告)日:2013-03-14
Heterocyclic compounds, and pharmaceutical compositions thereof, are disclosed as RORγt modulators that have a formula represented by the following:
and wherein n1, n2, R
1
, R
2
, R
3
, and R
4
are as described herein. These compounds may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, inflammatory conditions, autoimmune disorders, cancer, and graft-versus-host disease.